Reaction

Viraemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,374 reports · 92 co-occurring drugs

As of the last recalculation, Viraemia appears in 1,374 FAERS reports alongside 92 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 152.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Thiotepa	90	152.7	154.2
Everolimus Tablets	125	124.1	125.1
Pegaspargase	79	103.6	104.3
Basiliximab	74	100.7	101.3
Mercaptopurine	96	90.1	90.6
Fludarabine Phosphate	177	78.1	78.5
Alemtuzumab	93	78.1	78.4
Melphalan	95	67.9	68.2
Melphalan Hydrochloride	99	64.4	64.6
Anti-Thymocyte Globulin (Rabbit)	32	61.5	61.7
Lamivudine Oral	94	60.3	60.6
Valganciclovir Hydrochloride Powder,	45	57.7	58.0
Cabotegravir	29	55.6	55.8
Sirolimus	44	51.1	51.2
Lamivudine	96	50.5	50.7
Tacrolimus Ointment 0.1%	310	48.4	48.5
Tacrolimus Extended-Release Capsules	310	48.3	48.4
Filgrastim	106	46.2	46.3
Mesna Injection	23	42.9	43.0
Mycophenolate Mofetil	301	42.7	42.8
Mycophenolate Mofetil Hydrochloride	301	42.6	42.7
Tacrolimus	333	42.2	42.3
Mesna	23	42.1	42.2
Valganciclovir	50	41.7	41.8
Valganciclovir Hydrochloride	50	41.7	41.8
Everolimus	125	40.8	40.9
Ganciclovir	27	40.7	40.8
Ganciclovir Sodium	27	39.4	39.5
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	45	38.9	39.0
Ritonavir 100 Mg	35	36.4	36.5
Cytarabine	127	35.2	35.3
Darunavir	33	33.8	33.9
Vincristine Sulfate	61	33.0	33.0
Etoposide	141	32.3	32.3
Efavirenz	23	31.8	31.8
Tenofovir Disoproxil Fumarate Tablets	16	28.4	28.4
Cyclosporine	173	26.8	26.8
Abacavir Sulfate	16	25.2	25.2
Mycophenilic Acid	33	24.7	24.7
Zidovudine	21	24.1	24.2
Busulfan	24	23.5	23.5
Methylprednisolone	184	23.1	23.2
Mycophenolic Acid	47	23.0	23.0
Anti-Itch	93	22.5	22.5
Anti-Pruritic	93	22.5	22.5
Antipruritic (Anti-Itch)	93	22.5	22.5
Cool Relief Gel With Aloe	93	22.5	22.5
Drs. Hydrocortisone	93	22.5	22.5
Hydrocortisone Continuous Spray	93	22.5	22.5
Hydrocortisone Spray	93	22.5	22.5
Anti-Itch Cream	93	22.5	22.5
Hydrocortisone Lotion	93	22.5	22.5
Hydrocortisone Cream 1%	93	22.5	22.5
Hydrocortisone Cream 1/2%	93	22.5	22.5
Hydrocortisone 1%	93	22.4	22.5
Hydrocortisone Cream	93	22.4	22.4
Anakinra	24	22.3	22.3
Prednisolone	222	22.0	22.1
Prednisolone Oral	222	22.0	22.1
Prednisolone Oral Solution	222	22.0	22.1
Ritonavir	41	21.9	21.9
Hydrocortisone Acetate	93	20.7	20.7
Cyclophosphamide Injection, Solution	198	19.6	19.6
Cyclophosphamide	198	19.6	19.6
Cyclophosphamide For Injection	198	19.6	19.6
Atovaquone	10	18.9	19.0
Nevirapine	11	18.6	18.6
Hydrocortisone	94	17.1	17.1
Entecavir	13	17.0	17.0
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	11	16.7	16.7
Methylprednisolone Acetate	8	15.2	15.2
Micafungin Sodium	8	14.4	14.4
Daspone	9	14.1	14.1
Dapsone Gel, 5%	9	14.1	14.1
Dapsone	9	12.8	12.9
Raltegravir	13	12.0	12.0
Tenofovir Disoproxil Fumarate	23	10.7	10.7
Atazanavir	10	10.6	10.6
Romiplostim	9	9.1	9.1
Bleomycin Sulfate	6	8.8	8.8
Ruxolitinib	39	8.5	8.5
Dolutegravir Sodium	5	8.4	8.4
Baricitinib	5	7.9	7.9
Emtricitabine And Tenofovir Disoproxil Fumarate	21	7.1	7.1
Sofosbuvir	8	6.2	6.2
Ixazomib	11	5.8	5.8
Blinatumomab	4	5.8	5.8
Ribavirin	24	5.7	5.7
Glecaprevir And Pibrentasvir	4	5.5	5.5
Axicabtagene Ciloleucel	3	4.6	4.6
Emtricitabine And Tenofovir Alafenamide	3	4.0	4.0
Velpatasvir And Sofosbuvir	3	3.5	3.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.